ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,848Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 676

$1.49M Total Retail Price of All Prescriptions

Rank: 16 out of 676

647 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 647 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

27% of this provider’s 647 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 17,666 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
SIMVASTATIN 1,081 664 1 6
FUROSEMIDE 963 662 2 4
HYDROCODONE-ACETAMINOPHEN 873 381 S3 3 1
AMLODIPINE BESYLATE 738 553 4 3
OMEPRAZOLE 723 451 5 2
POTASSIUM CHLORIDE 499 316 6 9
NIASPAN 458 330 7 162
LEVOTHYROXINE SODIUM 435 349 8 7
METFORMIN HCL 416 289 9 8
ZOLPIDEM TARTRATE 405 198 10 21
ATORVASTATIN CALCIUM 374 263 11 20
METOPROLOL TARTRATE 370 266 12 22
CITALOPRAM HBR 359 258 13 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 356 239 14 16
GABAPENTIN 346 240 15 10
PRAVASTATIN SODIUM 333 280 16 11
LISINOPRIL 333 209 16 5
RANITIDINE HCL 300 230 18 27
WARFARIN SODIUM 282 225 19 18
DONEPEZIL HCL 281 250 20 24
ATENOLOL 269 151 21 25
CARVEDILOL 262 165 22 15
CLONIDINE HCL 256 122 23 32
KLOR-CON M20 249 190 24 67
MELOXICAM 248 164 25 13
DIOVAN HCT 240 201 26 41
LOVASTATIN 240 192 26 33
METOPROLOL SUCCINATE 239 166 28 14
HYDROCHLOROTHIAZIDE 239 154 28 12
ALENDRONATE SODIUM 234 182 30 61
CILOSTAZOL 207 157 31 123
RAMIPRIL 206 132 32 86
LOSARTAN POTASSIUM 203 144 33 34
DIOVAN 201 140 34 37
TAMSULOSIN HCL 194 157 35 38
CRESTOR 175 121 36 29
LANTUS 173 97 37 55
FENOFIBRATE 164 84 38 90
BENAZEPRIL HCL 159 104 39 58
CLOPIDOGREL 158 109 40 28
GEMFIBROZIL 153 114 41 137
LOSARTAN-HYDROCHLOROTHIAZIDE 149 82 42 51
NIFEDIPINE ER 145 107 43 100
GLIMEPIRIDE 144 112 44 30
EVISTA 135 126 45 119
PANTOPRAZOLE SODIUM 129 100 46 42
PREDNISONE 129 103 46 53
NOVOLOG 127 62 48 134
SYNTHROID 126 72 49 48
ALLOPURINOL 125 87 50 31
ACTOS 123 70 51 106
METFORMIN HCL ER 121 74 52 63
AMLODIPINE BESYLATE-BENAZEPRIL 120 92 53 44
PLAVIX 118 80 54 40
NAMENDA 116 109 55 35
COLCRYS 115 84 56 122
DIGOXIN 114 99 57 52
NEXIUM 113 77 58 23
QUETIAPINE FUMARATE 111 65 59 72
CEFUROXIME 108 78 60 121
TRICOR 107 46 61 126
AGGRENOX 106 69 62 147
FENTANYL 106 66 S2 62 93
MIRTAZAPINE 104 93 64 59
SEROQUEL 104 86 64 135
NOVOLOG FLEXPEN 100 34 66 226
MECLIZINE HCL 97 65 67 83
LANTUS SOLOSTAR 97 20 67 169
SERTRALINE HCL 97 35 67 26
TRAMADOL HCL 95 74 70 19
LIPITOR 95 79 70 94
NOVOLIN R 95 72 70 153
TIZANIDINE HCL 93 56 73 68
BYSTOLIC 92 31 74 96
DICLOFENAC SODIUM 88 57 75 142
PHENYTOIN SODIUM EXTENDED 87 73 76 88
LACTULOSE 87 41 76 110
ESCITALOPRAM OXALATE 87 39 76 73
CARISOPRODOL 87 21 R 76 60
SUCRALFATE 86 64 80 187
ISOSORBIDE MONONITRATE ER 85 60 81 54
LYRICA 85 36 81 57
ENALAPRIL-HYDROCHLOROTHIAZIDE 83 62 83 208
DETROL LA 83 30 83 166
PROAIR HFA 83 50 83 79
LEVEMIR 82 52 86 157
CHLORTHALIDONE 81 11 87 164
SPIRONOLACTONE 81 43 87 62
GUANFACINE HCL 81 53 R 87 250
LEVETIRACETAM 80 13 90 138
CIPROFLOXACIN HCL 79 51 91 45
LOVAZA 77 39 92 183
JANUVIA 77 52 92 78
NITROFURANTOIN MONO-MACRO 75 48 94 182
SYMBICORT 72 33 95 189
VERAPAMIL ER 72 62 95 101
POLYETHYLENE GLYCOL 3350 71 53 97 56
AMIODARONE HCL 70 48 98 154
PAROXETINE HCL 69 62 99 65
METOLAZONE 69 39 99 172
PROMETHAZINE HCL 69 47 R 99 75
NAPROXEN SODIUM 69 40 99 194
VESICARE 66 48 103 201
BENZTROPINE MESYLATE 66 42 R 103 129
IBUPROFEN 65 31 105 102
ZETIA 65 49 105 89
GLYBURIDE-METFORMIN HCL 64 35 R 107 76
CYMBALTA 64 38 107 47
FLUOXETINE HCL 64 48 107 70
HUMALOG 64 13 107 230
ADVAIR DISKUS 62 38 111 87
ATENOLOL-CHLORTHALIDONE 62 47 111 142
PRANDIN 61 61 113 389
DIVALPROEX SODIUM 61 0 113 99
AVODART 60 46 115 199
OXYCODONE HCL 59 25 S2 116 165
TRAZODONE HCL 59 31 116 36
NABUMETONE 59 23 116 179
LEVEMIR FLEXPEN 58 40 119 192
MEGESTROL ACETATE 58 56 R 119 111
ABILIFY 57 26 121 133
DILTIAZEM ER 57 40 121 118
CYCLOBENZAPRINE HCL 57 19 R 121 50
FAMOTIDINE 56 41 124 64
PIOGLITAZONE HCL 56 21 R 124 266
SPIRIVA 55 48 126 97
SULINDAC 53 21 127 259
TRIAMCINOLONE ACETONIDE 52 34 128 191
HYDRALAZINE HCL 51 36 129 77
TORSEMIDE 51 28 129 159
HALOPERIDOL 51 38 129 158
AMITRIPTYLINE HCL 50 35 R 132 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.